PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PositiveID Corp (PSID) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7868
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products include firefly Dx systems, m-band, thermometer, and ENG mobile system. PositiveID’s technologies offer research and white papers, which include identification of zika virus on firefly Dx, PSID market opportunities, and ricin detection assay. The company’s technologies are used for airborne pathogen detection, rapid biological diagnostics and sample preparation applications. The company operates its offices in Delray Beach and Pleasanton, the US. PositiveID is headquartered in Delray Beach, Florida, the US.

PositiveID Corp (PSID) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
PositiveID Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
PositiveID Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
PositiveID Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
PositiveID Corp, Medical Equipment, Deal Details 11
Asset Purchase 11
ExcitePCR to Acquire FireflyDX Technology from PositiveID 11
Partnerships 12
PositiveID Enters Into Licensing Agreement With Smart Glucose Meter For iglucose Technology 12
PositiveID Enters into Co-Development Agreement with USSOCOM 13
Equity Offering 14
PositiveID Announces Private Placement Of Shares For US$5 Million 14
Debt Offering 15
PositiveID Completes First Tranche Of Private Placement Of Convertible Debentures For US$0.6 Million 15
Asset Transactions 16
ExcitePCR to Acquire FireflyDX Technology from PositiveID 16
PositiveID Completes Sale Of VeriChip And Health Link Businesses To VeriTeQ 17
Acquisition 19
PositiveID Acquires Thermomedics from Sanomedics 19
PositiveID Corporation Sells Stake In VeriTeQ For US$0.75 Million 20
PositiveID Corp – Key Competitors 21
PositiveID Corp – Key Employees 22
PositiveID Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Apr 03, 2018: PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year 25
Nov 14, 2017: PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year 27
Aug 15, 2017: PositiveID Reports Second Quarter 2017 Results 29
May 16, 2017: PositiveID Reports First Quarter 2017 Results 30
May 01, 2017: PositiveID Announces Highlights for First Quarter 2017 31
Apr 03, 2017: PositiveID Reports 2016 Results; Revenue of $5.6 Million, up 89% Year over Year 32
Corporate Communications 33
Sep 26, 2017: PositiveID Subsidiary ExcitePCR Announces Board of Advisors 33
Aug 24, 2017: PositiveID’s Subsidiary, ExcitePCR, Hires Thirty-Year Marketing Veteran, David L. Politis, as its Chief Marketing & Sales Officer 34
May 30, 2017: PositiveID Subsidiary ExcitePCR Names Chief Science Officer 35
Product News 36
Nov 27, 2017: PositiveID to Present at the LD MICRO “Main Event” Investor Conference 36
Sep 18, 2017: PositiveID’s ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel Today 37
Apr 24, 2017: PositiveID Updates Report for its Molecular Diagnostics, Mobile Labs and Medical Device Businesses with Addressable Markets Exceeding $30 Billion 38
Jan 25, 2017: PositiveID to Present at RedChip’s Global Online Growth Conference 39
Other Significant Developments 40
Jan 17, 2018: PositiveID’s E-N-G Mobile Systems 2017 Bookings Increase 100% Year Over Year 40
Jan 10, 2018: PositiveID Announces 2017 Highlights and Projects Continued 30% Growth 41
Nov 28, 2017: PositiveID Projects Revenue Growth of More Than 30% Year-over-Year through First Quarter of 2018 42
Oct 09, 2017: PositiveID Announces Highlights for the Third Quarter of 2017 43
Jun 28, 2017: PositiveID Announces Highlights for the First Half of 2017 44
Mar 14, 2017: PositiveID’s E-N-G Mobile Systems’ 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter 45
Feb 21, 2017: PositiveID Announces 2016 Highlights 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
PositiveID Corp, Medical Equipment, Key Facts, 2017 2
PositiveID Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
PositiveID Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
PositiveID Corp, Deals By Market, 2012 to YTD 2018 9
PositiveID Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
ExcitePCR to Acquire FireflyDX Technology from PositiveID 11
PositiveID Enters Into Licensing Agreement With Smart Glucose Meter For iglucose Technology 12
PositiveID Enters into Co-Development Agreement with USSOCOM 13
PositiveID Announces Private Placement Of Shares For US$5 Million 14
PositiveID Completes First Tranche Of Private Placement Of Convertible Debentures For US$0.6 Million 15
ExcitePCR to Acquire FireflyDX Technology from PositiveID 16
PositiveID Completes Sale Of VeriChip And Health Link Businesses To VeriTeQ 17
PositiveID Acquires Thermomedics from Sanomedics 19
PositiveID Corporation Sells Stake In VeriTeQ For US$0.75 Million 20
PositiveID Corp, Key Competitors 21
PositiveID Corp, Key Employees 22
PositiveID Corp, Other Locations 23
PositiveID Corp, Subsidiaries 23

List of Figures
PositiveID Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
PositiveID Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
PositiveID Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Land Securities Group Plc:企業のM&A・事業提携・投資動向
    Land Securities Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Land Securities Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Business Development Bank Of Canada:企業の戦略・SWOT・財務分析
    Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report Summary Business Development Bank Of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Texwinca Holdings Limited:企業の戦略・SWOT・財務分析
    Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DalCor Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DalCor Pharmaceuticals Inc (DalCor Pharmaceuticals) researches and develops precision medicine for patients suffering from cardiovascular diseases. The company is engaged in development of Dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor which is intended to reduce cardiova …
  • Hooters of America, LLC :企業の戦略・SWOT・財務情報
    Hooters of America, LLC - Strategy, SWOT and Corporate Finance Report Summary Hooters of America, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Endotronix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Endotronix Inc (Endotronix) is a medical technology company that offers digital health solutions. The company offers Cordella Heart Failure System with an implantable wireless pulmonary artery sensor for early detection of worsening heart failure. Endotronix’s solution includes an implanted …
  • Odebrecht SA:電力:M&Aディール及び事業提携情報
    Summary Odebrecht S.A. (Odebrecht) is a diversified company. It carries out engineering and infrastructure construction services, development and operation of energy and infrastructure projects and real estate development services. The company executed various engineering and construction projects s …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • FANUC CORPORATION:企業の戦略・SWOT・財務分析
    FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report Summary FANUC CORPORATION - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Guerbet SA (GBT):医療機器:M&Aディール及び事業提携情報
    Summary Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imagin …
  • Koc Holding AS:企業の戦略・SWOT・財務情報
    Koc Holding AS - Strategy, SWOT and Corporate Finance Report Summary Koc Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eagle Oil & Gas Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Eagle Oil & Gas Co (Eagle Oil) is an oil and gas company that acquires, develops, regulates, and explores oil and gas reserves. The company offers contract drilling services. It undertakes projects such as Haynesville, Oklahoma stack, West Raymond Field, Marcellus, Woodford, Lower Cotton Val …
  • Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析
    Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Avaya Inc.:企業の戦略・SWOT・財務情報
    Avaya Inc. - Strategy, SWOT and Corporate Finance Report Summary Avaya Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析
    Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Electric Power Development Co Ltd (9513):電力:M&Aディール及び事業提携情報
    Summary Electric Power Development Co., Ltd. (J-Power) is a wholesale electric utility that supplies hydroelectric and thermal power. It owns and operates a network of hydroelectric, thermal, wind and geothermal power plants. The group provides electricity and transmission services to major electric …
  • Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析
    Summary Ergomed Plc (Ergomed) is a provider of drug development and clinical research services. The company offers clinical development, trial management, pharmacovigilance, medical monitoring and writing, project management and monitoring, regulatory affairs, quality, data and site management, clin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆